HIV & AIDS

Scientists find potential cellular target for HIV therapies

Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues ...

Medications

FDA approves Sunlenca for treatment-resistant HIV

The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...

HIV & AIDS

Recommendations updated for treatment, prevention of HIV

In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antiretroviral drugs ...

HIV & AIDS

COVID vaccines also help protect HIV patients

People infected with HIV who receive antiretroviral therapy form antibodies against SARS-CoV-2 after being vaccinated against COVID with mRNA vaccines. Their immune response to the vaccination is, however, less strong than ...

page 8 from 40